MIRA INFORM REPORT

 

 

Report Date :

26.03.2013

 

IDENTIFICATION DETAILS

 

Name :

PHARMACHEMICALS HANDELS GMBH

 

 

Registered Office :

Spaldingstr. 210, D 20097 Hamburg

 

 

Country :

Germany

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

06.12.1996

 

 

Com. Reg. No.:

HRB 62976

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Agents involved in the sale of fuels, ores, metals and industrial chemicals

 

 

No. of Employees :

05

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

 

 

Payment Behaviour :

Usually Correct 

 

 

Litigation :

Clear 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Germany

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

germany - ECONOMIC OVERVIEW

 

The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, contributed to strong growth in 2006 and 2007 and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 6.0% in 2011. GDP contracted 5.1% in 2009 but grew by 3.6% in 2010, and 2.7% in 2011. The recovery was attributable primarily to rebounding manufacturing orders and exports - increasingly outside the Euro Zone. Germany's central bank projects that GDP will grow 0.6% in 2012, a reflection of the worsening euro-zone financial crisis and the financial burden it places on Germany as well as falling demand for German exports. Domestic demand is therefore becoming a more significant driver of Germany's economic expansion. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's budget deficit to 3.3% in 2010, but slower spending and higher tax revenues reduce the deficit to 1.7% in 2011, below the EU's 3% limit. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela Merkel announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany hopes to replace nuclear power with renewable energy. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its energy and 46% of its base-load electrical production.

 

 

 

Source : CIA

 

 


Company name

 

PHARMACHEMICALS Handels GmbH

 

 

Company address

 

Spaldingstr. 210

D 20097 Hamburg

Telephone:        040/2369492

Telefax:            040/2369368

Homepage:       www.pharmachemicals-gmbh.de

E-mail: info@pharmachemicals-gmbh.de

           

 

Company Status

 

active

 

 

Synthesis

 

LEGAL FORM               Private limited company

Date of foundation:       1996

Shareholders'

agreement:                    18.09.1996

Registered on:              06.12.1996

Commercial Register:    Local court 20355 Hamburg

under:                                       HRB 62976

Share capital:                 EUR             50,000.00

 

 

Shareholder

 

Dr. Avraam Sarafidis

Grenzknick 7

D 22043 Hamburg

born: 18.11.1961

Share:             EUR             50,000.00

 

 


Manager

 

Dr. Avraam Sarafidis

Grenzknick 7

D 22043 Hamburg

having sole power of representation

born: 18.11.1961

Profession: Chemist

 

 

Proxy

 

Michaela Sarafidis

D 20097 Hamburg

having sole power of representation

born: 26.06.1958

 

 

COMPANY HISTORY

 

11.07.1997 - 31.12.1998  TRANSPHARMA and CHEMICALS Handels GmbH

                         Gotenstr. 13

                         D 20097 Hamburg

                         Private limited company

 

 

BUSINESS ACTIVITIES

 

Sectors

·         46120   Agents involved in the sale of fuels, ores, metals andindustrial chemicals

·         46461   Wholesale of pharmaceutical goods

·         46760   Wholesale of other intermediate goods

 

 

FINANCIAL INFORMATION

 

Payment experience:     within agreed terms

 

Negative information:    We have no negative information at hand.

 

Balance sheet year:       2011

 

 

 

REAL ESTATE

 

Type of ownership:        Tenant

Address                        Spaldingstr. 210

                                    D 20097 Hamburg

 

Real Estate of:              Dr. Avraam Sarafidis

Type of ownership:        unknown

Address                        Grenzknick 7

                                    D 22043 Hamburg

 

Land register documents were not available.

 

 

BANKERS

 

Principal bank

COMMERZBANK, HAMBURG

Sort. code: 20040000, BIC: COBADEHHXXX

 

 

FINANCIAL FIGURES

 

Profit:              2011               EUR          1,129,328.00

Ac/ts receivable:                       EUR          3,846,778.00

Liabilities:                            EUR            933,483.00

Employees:                                                      5

- Freelancer:                                                   1

 

The aforementioned business figures may partly be estimated information based on average values in the line of business.

 

 

BALANCE SHEETS

 

Balance sheet ratios 01.01.2011 - 31.12.2011

Equity ratio [%]:                 73.55

Liquidity ratio:                  10.00

Return on total capital [%]:      21.39

 

Balance sheet ratios 01.01.2010 - 31.12.2010

Equity ratio [%]:                 61.84

Liquidity ratio:                  10.00

Return on total capital [%]:      20.04

 

Balance sheet ratios 01.01.2009 - 31.12.2009

Equity ratio [%]:                 59.71

Liquidity ratio:                   8.94

Return on total capital [%]:      20.20

 

Balance sheet ratios 01.01.2008 - 31.12.2008

Equity ratio [%]:                 48.04

Liquidity ratio:                   3.24

Return on total capital [%]:      16.03

 

Equity ratio

The equity ratio indicates the portion of the equity as compared

to the total capital. The higher the equity ratio, the better the

economic stability (solvency) and thus the financial autonomy of

a company.

 

Liquidity ratio

The liquidity ratio shows the proportion between adjusted

receivables and net liabilities. The higher the ratio, the lower

the company's financial dependancy from external creditors.

 

Return on total capital

The return on total capital shows the efficiency and return on

the total capital employed in the company. The higher the return

on total capital, the more economically does the company work

with the invested capital.

 

Type of balance

sheet:               Company balance sheet

 

Financial year:      01.01.2011 - 31.12.2011

 

ASSETS                                  EUR          5,280,289.19

 Fixed assets                           EUR             76,788.12

  Tangible assets                       EUR              7,012.12

   Other / unspecified tangible assets  EUR              7,012.12

  Financial assets                      EUR             69,776.00

   Other / unspecified financial assets EUR             69,776.00

 Current assets                         EUR          5,181,291.46

  Stocks                                EUR            524,656.31

  Accounts receivable                   EUR          3,846,777.62

   Other debtors and assets             EUR          3,846,777.62

  Liquid means                          EUR            809,857.53

 Remaining other assets                 EUR             22,209.61

  Accruals (assets)                     EUR             22,209.61

 

LIABILITIES                             EUR          5,280,289.19

 Shareholders' equity                   EUR          3,883,810.49

  Capital                               EUR             50,000.00

   Subscribed capital (share capital)   EUR             50,000.00

  Balance sheet profit/loss (+/-)       EUR          3,833,810.49

   Profit / loss brought forward        EUR          2,704,482.23

   Annual surplus / annual deficit      EUR          1,129,328.26

 Provisions                             EUR            462,995.51

 Liabilities                            EUR            933,483.19

  Other liabilities                     EUR            933,483.19

   Unspecified other liabilities        EUR            933,483.19

 

Type of balance

sheet:               Company balance sheet

 

Financial year:      01.01.2010 - 31.12.2010

 

ASSETS                                  EUR          4,694,998.85

 Fixed assets                           EUR             77,727.67

  Tangible assets                       EUR              7,951.67

   Other / unspecified tangible assets  EUR              7,951.67

  Financial assets                      EUR             69,776.00

   Other / unspecified financial assets EUR             69,776.00

 Current assets                         EUR          4,593,027.69

  Stocks                                EUR            501,252.18

  Accounts receivable                   EUR          3,251,522.51

   Other debtors and assets             EUR          3,251,522.51

  Liquid means                          EUR            840,253.00

 Remaining other assets                 EUR             24,243.49

  Accruals (assets)                     EUR             24,243.49

 

LIABILITIES                             EUR          4,694,998.85

 Shareholders' equity                   EUR          2,903,251.63

  Capital                               EUR             50,000.00

   Subscribed capital (share capital)   EUR             50,000.00

  Balance sheet profit/loss (+/-)       EUR          2,853,251.63

   Profit / loss brought forward        EUR          1,912,574.14

   Annual surplus / annual deficit      EUR            940,677.49

 Provisions                             EUR            764,804.91

 Liabilities                            EUR          1,026,942.31

  Other liabilities                     EUR          1,026,942.31

   Unspecified other liabilities        EUR          1,026,942.31

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.09

UK Pound

1

Rs.82.47

Euro

1

Rs.70.49

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.